Covid-19: Vaccination Programme

Baroness Thornton Excerpts

Tuesday 22nd February 2022 Lords Chamber

[Lord Sharpe of Epsom (Con)]

My Lords, the UK is in total agreement with the noble Lord that vaccine inequity is shocking. We are committed to supporting global vaccination and equitable access in the poorest countries. That is why we used our G7 presidency in 2021 to push for more commitments and continue to play a leading role with COVAX and other partners in strengthening procurement and delivery efforts with partner Governments. We have delivered £548 million to COVAX’s advance market commitment, which will help to deliver up to 1.8 billion doses for developing countries in 2022. To date, more than 1.19 billion vaccines have been delivered globally through COVAX to 144 participants, including 1 billion doses to almost all of the AMC-eligible countries. Some 86 of those countries are eligible, and 44 of them are in Africa.

[Baroness Thornton (Lab)]

My Lords, does the Minister agree that it is unacceptable that, through mismanagement, this Government allowed more than 500,000 vaccines that could have gone to developing countries to be destroyed? Given that the UK has the expertise, technology, resources and production capacity to vaccinate the whole world, why is the vaccination gulf between us and the global south so great?

[Lord Sharpe of Epsom (Con)]

My Lords, I thank the noble Baroness for her question, which relates to shelf life. Decisions on donation are driven by the availability of vaccines from domestic supply. Once the Health Secretary is confident that vaccines are available to donate, the Foreign Secretary prioritises how they are shared. Avoiding vaccine expiry and the wastage of vaccines is a UK core objective, determining when and where we share and deploy our doses. For all bilateral donations, we have sought assurances that recipients have the capacity to roll out the quantity of doses in line with the national vaccination programmes ahead of their expiry date. Vaccines delivered by COVAX are delivered in consultation with countries and distributed in line with the WHO’s equitable allocation framework.